Isracann Biosciences Receives Land Use & Facility Approvals from Israeli Land Authority and Amends Warrants
28 nov. 2019 00h05 HE
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Nov. 28, 2019 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier...